Nestle Increases Health Care Investment With Galderma Control
This article was originally published in The Tan Sheet
Executive Summary
Galderma will be the “foundation” of a new division to be called Nestle Skin Health SA, said Nestle Chairman Peter Brake-Letmathe. L’Oreal will give Nestle its 50% stake in Galderma and $4.6 billion in cash to buy back 8% of its own stock from Nestle.